Welcome to Wopular's coverage of Acquisition, Actavis.
Wopular aggregates news headlines from the top newspapers and
news sources. To the right are articles about
Acquisition, Actavis that have been featured on main sections
of the site.
Below are topics about Acquisition, Actavis. (Click on "all"
to view all articles related to the topic, including articles NOT about
Acquisition, Actavis.
Watson Pharmaceuticals Inc is close to buying Swiss-based Actavis for around $7 billion, marking the latest deal between generics companies racing to achieve economies of scale, three sources familiar with the matter said.